Transcriptomics

Dataset Information

0

Effect of knocking down FOXP4 and YAP1 in gastric cancer cells


ABSTRACT: The Hippo-YAP1 pathway is an evolutionally conserved signaling cascade that controls organ size and tissue regeneration. Its dysregulation has been well-studied to promote tumor initiation and progression, including gastric cancer (GC). Although the Hippo-YAP1 signaling pathway regulates the expression of thousands of target genes, how these target genes contribute to the oncogenic program driven by YAP1 remains unknown. Here we identified the vital role of FOXP4 in YAP1-driven gastric carcinogenesis by maintaining stemness and promoting peritoneal metastasis. Knocking down FOXP4 impairs GC spheroid formation and inhibits stemness marker expression, while its upregulation potentiates the cancer cells with more stemness. RNA-seq analysis revealed SOX12 as functional downstream of FOXP4 in the YAP1-induced carcinogenesis. Targeting FOXP4 by 42-(2-Tetrazolyl) rapamycin in GC cells enhanced the 5-FU efficacies. Our findings have unveiled FOXP4 as a novel stemness marker that promotes tumorigenesis by upregulating SOX12. Additionally, we have identified FOXP4 as a direct target for modulating YAP1 signaling in GC. Therefore, the YAP1-FOXP4-SOX12 axis presents a promising therapeutic target for GC.

ORGANISM(S): Homo sapiens

PROVIDER: GSE267854 | GEO | 2024/07/13

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA1113533 | ENA
2022-04-06 | GSE199559 | GEO
2023-11-07 | GSE199170 | GEO
2023-11-07 | GSE199171 | GEO
2024-05-16 | GSE267263 | GEO
2024-12-11 | GSE283517 | GEO
2020-02-16 | GSE113045 | GEO
2024-02-01 | GSE242332 | GEO
2023-04-12 | PXD040200 | Pride
2022-04-06 | GSE199570 | GEO